New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients

April 19th, 2008 by admin

Adding capecitabine, a take that inhibits polymer reasoning and slows the ontogeny of growth tissue, to docetaxel, in patients with primeval boob cancer, leads to more toxicities and does not meliorate the effectualness of treatment, a Teutonic individual told the 6th dweller Breast person Conference on Thursday. Previously, much a compounding had reinforced enduring activity in metastatic disease, where the cancer has distribute to another parts of the body.

Tags: , , , , , ,

Posted in Cancer |

Related posts

Comments are closed.